The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter Hima Bindu Potluri has disclosed that 30,00,000 (30 lakh) equity shares were released from a Non-Disposal Undertaking (NDU) on 19 August 2025, and the same number of shares were pledged on 20 August 2025. The net effect is essentially neutral — one form of encumbrance (NDU) has been swapped for another (pledge). The filing is made under Regulation 29 and 31 of the SEBI SAST Regulations, 2011. The Annexure II on reasons for encumbrance appears incomplete, with key debt-related details left blank in the document.
The overall encumbrance level on promoter shares remains unchanged, so there is no immediate dilution risk or change in promoter control. However, the shift from NDU to pledge suggests the promoter may be raising funds or providing collateral, which retail investors should monitor for any future pledge invocation or invocation-related disclosures.